Fig. 2

Kaplan–Meier curves for MACE (a) and cardiac death (b) during follow-up for successful CTO-PCI versus medical therapy in total patients with and without diabetes. CTO chronic total occlusion, DM diabetes mellitus, MACE major adverse cardiovascular events, PCI percutaneous coronary intervention